Oxidative stress in vascular disease and its pharmacological prevention.
about
Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategiesTreating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisReconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).The Antioxidant Machinery of Young and Senescent Human Umbilical Vein Endothelial Cells and Their Microvesicles.Tetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings: Implications for Antioxidant Therapy of Vascular DiseasesEffects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney diseaseNew approaches to the design and discovery of therapies to prevent erectile dysfunction.The role of reactive oxygen species in microvascular remodeling.Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo.The COP9 signalosome and vascular function: intriguing possibilities?Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic ShockAn Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity.PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice.Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.Influence of Sorghum Kafirin on Serum Lipid Profile and Antioxidant Activity in Hyperlipidemic Rats (In Vitro and In Vivo Studies).Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure.Effect of oxidative stress on heme oxygenase-1 expression in patients with gestational diabetes mellitus.Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.Protective effects of resveratrol against mancozeb induced apoptosis damage in mouse oocytes.Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.Iron, oxidative stress, and redox signaling in the cardiovascular system.Modulation of nitric oxide by flavonoids.Diabetes and the brain: oxidative stress, inflammation, and autophagy.Resveratrol and endothelial nitric oxide.Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.The effect of different training modes on skeletal muscle microvascular density and endothelial enzymes controlling NO availability.Are reactive oxygen species still the basis for diabetic complications?Oxidative stress by inorganic nanoparticles.Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice.Antioxidant effects of resveratrol in the cardiovascular system.Influence of Laccase and Tyrosinase on the Antioxidant Capacity of Selected Phenolic Compounds on Human Cell Lines.Inhibition of Mitochondrial Clearance and Cu/Zn-SOD Activity Enhance 6-Hydroxydopamine-Induced Neuronal Apoptosis.The role of perivascular adipose tissue in obesity-induced vascular dysfunctionVascular biology of hydrogen sulfide.A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers.
P2860
Q27009367-487EFBF0-994A-46E8-AF39-B0D952AEEF41Q28076034-83BF07DF-7D62-4818-A32E-08050D69DBFFQ28354735-9E8E1D8A-6447-4219-869F-95A840A9DBF8Q30874878-9052E9D8-E66D-4165-9545-1C525B7F279DQ33761211-4B0676FB-2C37-4762-9725-DA13BA12EF59Q33795049-103585BC-A394-426F-B8D9-1E8B09492CB1Q34199298-776B033F-A577-4D1F-996A-610314C73FABQ34554416-ED5E76C1-B5A4-4AF0-AA89-9FF17C058DC4Q34664336-1F82E945-D1E3-4B92-A6EE-823F8737A8FDQ34836065-C1ABA244-4F55-4B34-8576-7B62C9B8A6A1Q34978108-F14D50B9-BFC3-4092-A250-5A4BC2D123F9Q35671749-26317630-0189-46F9-BCCC-319F3B89FB7AQ35700589-724DA660-D176-4FD4-A1AB-7476956DACC4Q35855677-29620E29-C050-4F23-93F2-5BC25BDFE1F6Q35866267-7050F023-4FCE-44E4-A789-648C393B67E7Q36095865-7C2DECA7-977D-4C1C-B859-872E930F76B4Q36148599-BA85787C-500B-457A-821D-7A18B2F56679Q36260989-32F578AE-5823-4648-8955-D190B7F989EDQ36912685-D4BC9598-0B54-4DA7-A5C6-5EAB3F147276Q37434417-1F705FFC-3CCE-490A-90C5-E83426D02E95Q37604744-AEC6C6AA-9274-4252-91DC-127662068160Q37701582-93D214BB-B275-4B6D-A721-63F82273E47EQ37846181-7EE41884-D188-4E73-969C-9D6A4A9AE617Q38140700-A6361E5F-822E-4BC9-889E-AFA434FCFE1EQ38167610-AF1964A9-F153-4417-AA94-A8594659A5FAQ38216863-C1E1484A-36E4-41B1-BB32-7F27048E3374Q38217861-CB4EC968-8776-4106-9DBA-FF50EB535F27Q38248610-2732E862-8C62-4F38-9E27-F8BA814EEDB4Q38258814-5140A975-5C05-4C32-8A61-F70BDD8049A5Q38272306-18E49B21-AA37-40D0-839E-570B5F64AA05Q38391118-E5336616-3ADB-42AE-B694-7F451A291144Q38451253-E23BEAFB-E0CC-409C-B2D9-9233BE0588A0Q38584750-EEA05C23-5864-4B41-9076-7F6831E842B2Q38741534-B9E2B356-60D3-445F-965B-DB96D62E6995Q38802176-E3494F04-2081-47B9-ABF4-A77E10CD9375Q38833568-A3711533-970A-4868-B682-9A685461B9CCQ38915453-90546E10-38F4-4576-8F50-3F3573BE5B30Q38985853-DB987050-5E52-4D47-9C86-F055730611DAQ39113984-63A055FF-B06D-4E17-A734-FEBFBB6F3AF8Q39187718-29A3F0C8-DADE-4701-B299-9E61716BB959
P2860
Oxidative stress in vascular disease and its pharmacological prevention.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oxidative stress in vascular disease and its pharmacological prevention.
@en
type
label
Oxidative stress in vascular disease and its pharmacological prevention.
@en
prefLabel
Oxidative stress in vascular disease and its pharmacological prevention.
@en
P1476
Oxidative stress in vascular disease and its pharmacological prevention
@en
P2093
Sven Horke
Ulrich Förstermann
P304
P356
10.1016/J.TIPS.2013.03.007
P50
P577
2013-04-19T00:00:00Z